MLC1: A Promising New Target for Multiple Sclerosis Treatment Breakthroughs
MLC1: A Potential Game Changer in Multiple Sclerosis Research A groundbreaking discovery by researchers at the University Hospital Bonn (UKB), the University of Bonn, and FAU Erlangen-Nuremberg has identified a potential new target antigen in multiple sclerosis (MS): the membrane protein MLC1. This finding, published in Neurology Neuroimmunology & Neuroinflammation, represents a significant leap forward … Read more